• Medicina clinica · Jul 2024

    Role of neuromuscular blocking agents in the development of polyneuropathy and myopathy in critically ill patients.

    • Fernando Armestar, Sara Vitoria Rubio, Isabel Ojanguren Sabán, Jaume Coll-Cantí, and Hipólito Perez Molto.
    • Servicio de Medicina Intensiva, Hospital Universitario Germans Trias i Pujol, Barcelona, España; Departamento de Medicina, Universidad Autónoma de Barcelona, Barcelona, España. Electronic address: farmestar.germanstrias@gencat.cat.
    • Med Clin (Barc). 2024 Jul 2.

    BackgroundAcquired critical illness weakness (AWCIP) is the most frequent neuromuscular disease in intensive care medicine departments. Its importance is given by the prolongation of hospital stay and the delayed recovery it causes to patients after hospitalization. The main objective of this study was to investigate the association between neuromuscular blocking agents and the development of acquired weakness in critically ill patients.Material And MethodsWe conducted a prospective study of 103 critically ill patients who were periodically monitored with electromyography.ResultsThe development of AWCIP was observed in 63 patients. The group of patients who developed AWCIP had a significantly higher utilization of neuromuscular blocking agents than the group who did not develop AWCIP [79.4% vs 50%, OR:3.85 (1.63-9.39), p <0.02]; likewise, this group of patients had a longer ICU stay [32 days vs 14 days, OR: 1.11 (1.06-1.17), p <0. 001] and a longer mechanical ventilation time [24 days vs 9 days, OR:1.2 (1.11-1.32), p <0.001].ConclusionNeuromuscular blocking agents are a factor associated with the occurrence of AWCIP.Copyright © 2024 Elsevier España, S.L.U. All rights reserved.

      Pubmed     Copy Citation     Plaintext  

      Add institutional full text...

    Notes

     
    Knowledge, pearl, summary or comment to share?
    300 characters remaining
    help        
    You can also include formatting, links, images and footnotes in your notes
    • Simple formatting can be added to notes, such as *italics*, _underline_ or **bold**.
    • Superscript can be denoted by <sup>text</sup> and subscript <sub>text</sub>.
    • Numbered or bulleted lists can be created using either numbered lines 1. 2. 3., hyphens - or asterisks *.
    • Links can be included with: [my link to pubmed](http://pubmed.com)
    • Images can be included with: ![alt text](https://bestmedicaljournal.com/study_graph.jpg "Image Title Text")
    • For footnotes use [^1](This is a footnote.) inline.
    • Or use an inline reference [^1] to refer to a longer footnote elseweher in the document [^1]: This is a long footnote..

    hide…